Key Findings:  There is evidence for some promising new targets for the treatment of male lower urinary tract symptoms including the neural growth factor, the cannabinoid, the vanilloid, and the ATP pathways
Type of Study:  Meta-analysis
Study Result:  Positive
Study Location(s):  Italy, United States
Year of Pub:  2020
Cannabinoids Studied:  Endocannabinoid (unspecified)
Phytocannabinoid Source:  Not Applicable
Receptors Studied:  GPCR, TRPs